Plasma free serotonin as a marker for early detection of breast cancer recurrence

Anticancer Research

Volumn 34, Issue 3, 2014, Pages 1167-1169

  Fröbe, Ana ^a   Čičin Šain, Lipa ^b   Jones, Glenn ^c   Soldić, Željko ^a   Lukač, Josip ^a   Bolanča, Ante ^a   Kusić, Zvonko ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomarker; Breast cancer; Ca15.3; Plasma free serotonin; Recurrence

Indexed keywords

CA15.3 PROTEIN; SEROTONIN; TUMOR MARKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD DONOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LIMIT OF DETECTION; PROSPECTIVE STUDY; SEROTONIN BLOOD LEVEL; BLOOD; BREAST TUMOR; CA15.3; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; PLASMA FREE SEROTONIN; PROGNOSIS; RADIOIMMUNOASSAY; RECURRENT DISEASE; TUMOR RECURRENCE; VERY ELDERLY;

BIOMARKER; BREAST CANCER; CA15.3; PLASMA FREE SEROTONIN; RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SEROTONIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84899700774     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Siddiqui EJ, Thompson CS, Mikhailidis DP and Mumtaz FH: The role of serotonin in tumour growth (review). Oncol Rep 14: 1593-15937, 2005.
2. Deb C, Lakshimi C, Rayand C and Ray MR: Decrease in platelet serotonin level in uterine cervix cancer patients. Haematologia 31: 147-152, 2001.
3. Jungwirth N, Schrott KM, Wullich B and Krause FS: Serotonin used as prognostic marker of urological tumors. World J Urol 26: 499-504, 2008.
4. Pai VP, Marshall AM, Hernandez LL, Buckley AR and Horseman ND: Altered serotonin physiology in human breast cancers favours paradoxical growth and cell survival. Breast Cancer Res 11(6): R81, 2009.
5. Juhász C, Nahleh Z, Zitron I, Chugani DC, Janabi MZ, Bandyopadhyay S, Ali-Fehmi R, Mangner TJ, Chakraborty PK, Mittal S and Muzik O: Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. Nucl Med Biol 39(7): 926-932, 2012.
6. Duffy MJ: Serum tumour markers in breast cancer: Are they of clinical value? Clin Chem 52(3): 345-351, 2006.
7. Brand T and Anderson GM: The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 57(10): 1376-1386, 2011.
8. Kopparapu PK, Tinzl M, Anagnostaki L, Persson JL and Dizeyi N: Expression and localization of serotonin receptors in human breast cancer. Anticancer Res 33(2): 363-370, 2013.